These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27170154)

  • 1. The journey of exome sequencing from disease mutations discovery to clinical genomics.
    Alkuraya FS; Ku CS
    Hum Genet; 2016 Jun; 135(6):589. PubMed ID: 27170154
    [No Abstract]   [Full Text] [Related]  

  • 2. Opportunities and challenges of whole-genome and -exome sequencing.
    Petersen BS; Fredrich B; Hoeppner MP; Ellinghaus D; Franke A
    BMC Genet; 2017 Feb; 18(1):14. PubMed ID: 28193154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next generation sequencing: the technology we need in pediatric laboratories?
    Couderc R; Jonard L; Louha M
    Clin Biochem; 2011 May; 44(7):514-515. PubMed ID: 22036354
    [No Abstract]   [Full Text] [Related]  

  • 4. Exome sequencing explained: a practical guide to its clinical application.
    Seaby EG; Pengelly RJ; Ennis S
    Brief Funct Genomics; 2016 Sep; 15(5):374-84. PubMed ID: 26654982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exome sequencing: capture and sequencing of all human coding regions for disease gene discovery.
    Priya RR; Rajasimha HK; Brooks MJ; Swaroop A
    Methods Mol Biol; 2012; 884():335-51. PubMed ID: 22688718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More Pitfalls Related to Next-generation Sequencing (NGS).
    Sorscher S
    Am J Clin Oncol; 2016 Aug; 39(4):424. PubMed ID: 27465427
    [No Abstract]   [Full Text] [Related]  

  • 7. Genome sequencing in the clinic: the past, present, and future of genomic medicine.
    Prokop JW; May T; Strong K; Bilinovich SM; Bupp C; Rajasekaran S; Worthey EA; Lazar J
    Physiol Genomics; 2018 Aug; 50(8):563-579. PubMed ID: 29727589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Base-resolution stratification of cancer mutations using functional variomics.
    Yi S; Liu NN; Hu L; Wang H; Sahni N
    Nat Protoc; 2017 Nov; 12(11):2323-2341. PubMed ID: 28981122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of Clinical Whole-Exome and Whole-Genome Sequencing for Detection of Germline Variants in Inherited Disease.
    Hegde M; Santani A; Mao R; Ferreira-Gonzalez A; Weck KE; Voelkerding KV
    Arch Pathol Lab Med; 2017 Jun; 141(6):798-805. PubMed ID: 28362156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The next-generation sequencing revolution and its impact on genomics.
    Koboldt DC; Steinberg KM; Larson DE; Wilson RK; Mardis ER
    Cell; 2013 Sep; 155(1):27-38. PubMed ID: 24074859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exome and whole-genome sequencing for gene discovery: the future is now!
    Majewski J; Rosenblatt DS
    Hum Mutat; 2012 Apr; 33(4):591-2. PubMed ID: 22411407
    [No Abstract]   [Full Text] [Related]  

  • 12. NIH program to sequence 1,000 exomes.
    Cancer Discov; 2014 Jul; 4(7):OF1. PubMed ID: 25002615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The promise of nanopore technology: Nanopore DNA sequencing represents a fundamental change in the way that genomic information is read, with potentially big savings.
    Rosenstein J
    IEEE Pulse; 2014; 5(4):52-4. PubMed ID: 25029683
    [No Abstract]   [Full Text] [Related]  

  • 14. Next-generation sequencing and potential applications in fungal genomics.
    Sanmiguel P
    Methods Mol Biol; 2011; 722():51-60. PubMed ID: 21590412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genomic extension to the sequence of HLA-A*02:13, identified using third-generation sequencing.
    Liu YL; Lucas JAM; Turner TR; Marsh SGE; Mayor NP
    HLA; 2019 Nov; 94(5):437-438. PubMed ID: 31373766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safe sequencing depth to estimate the intra-host heterogeneity of viruses.
    Ren X; Jin Q
    Brief Funct Genomics; 2016 Jul; 15(4):275-7. PubMed ID: 26427942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance comparison of four commercial human whole-exome capture platforms.
    Shigemizu D; Momozawa Y; Abe T; Morizono T; Boroevich KA; Takata S; Ashikawa K; Kubo M; Tsunoda T
    Sci Rep; 2015 Aug; 5():12742. PubMed ID: 26235669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Massively parallel sequencing technology in pathogenic microbes.
    Tripathy S; Jiang RH
    Methods Mol Biol; 2012; 835():271-94. PubMed ID: 22183660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Exome and transcriptome sequencing as complementary approaches for disease gene identification].
    Rötig A
    Med Sci (Paris); 2017 Dec; 33(12):1045-1047. PubMed ID: 29261490
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of targeted sequence capture and high-throughput sequencing identifies a novel PKD1 mutation involved in adult polycystic kidney disease.
    Sha YK; Sha YW; Mei LB; Huang XJ; Wang X; Lin SB; Li L; Li P
    Gene; 2017 Nov; 634():1-4. PubMed ID: 28870863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.